Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer

被引：0
|
作者：
Zelin Hou
Yu Pan
Qinglin Fei
Yali Lin
Yuanyuan Zhou
Ying Liu
Hongdan Guan
Xunbin Yu
Xianchao Lin
Fengchun Lu
Heguang Huang
机构：
[1] Fujian Medical University Union Hospital,Department of General Surgery
[2] Fujian Medical University Union Hospital,The Cancer Center
[3] Fujian Medical University Union Hospital,Department of Geriatrics
[4] Quanzhou Hospital of Traditional Chinese Medicine,Department of Endocrinology
[5] Fujian Medical University Union Hospital,Department of Radiation Oncology
[6] Fujian Provincialial Hospital,Department of Pathology
来源：
Journal of Cancer Research and Clinical Oncology | 2021年 / 147卷
关键词：
VISTA; Immune checkpoints; Immunotherapy; Pancreatic cancer; Biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：517 / 531
页数：14
相关论文
共 50 条
  • [1] Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer
    Hou, Zelin
    Pan, Yu
    Fei, Qinglin
    Lin, Yali
    Zhou, Yuanyuan
    Liu, Ying
    Guan, Hongdan
    Yu, Xunbin
    Lin, Xianchao
    Lu, Fengchun
    Huang, Heguang
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (02) : 517 - 531
  • [2] Therapeutic potential of MET inhibitor combined with immune checkpoint blockade in pancreatic cancer
    Gao, Mei
    Lin, Miranda
    Yang, Yachao
    Kim, Joseph
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [3] The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer
    Xie, Xiaoxue
    Zhang, Junying
    Shi, Zhongyuan
    Liu, Wanmei
    Hu, Xinlei
    Qie, Chenxin
    Chen, Wenting
    Wang, Yan
    Wang, Li
    Jiang, Jingwei
    Liu, Jun
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [4] Expression of the immune checkpoint VISTA in breast cancer
    Liju Zong
    Shengwei Mo
    Shuangni Yu
    Yuncan Zhou
    Ming Zhang
    Jie Chen
    Yang Xiang
    [J]. Cancer Immunology, Immunotherapy, 2020, 69 : 1437 - 1446
  • [5] Expression of the immune checkpoint VISTA in breast cancer
    Zong, Liju
    Mo, Shengwei
    Yu, Shuangni
    Zhou, Yuncan
    Zhang, Ming
    Chen, Jie
    Xiang, Yang
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (08) : 1437 - 1446
  • [6] Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer
    Blando, Jorge
    Sharma, Anu
    Higa, Maria Gisela
    Zhao, Hao
    Vence, Luis
    Yadav, Shalini S.
    Kim, Jiseong
    Sepulveda, Alejandro M.
    Sharp, Michael
    Maitra, Anirban
    Wargo, Jennifer
    Tetzlaff, Michael
    Broaddus, Russell
    Katz, Matthew H. G.
    Varadhachary, Gauri R.
    Overman, Michael
    Wang, Huamin
    Yee, Cassian
    Bernatchez, Chantale
    Iacobuzio-Donahue, Christine
    Basu, Sreyashi
    Allison, James P.
    Sharma, Padmanee
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (05) : 1692 - 1697
  • [7] Immune Checkpoint Neuropilins as Novel Biomarkers and Therapeutic Targets for Pancreatic Cancer
    He, Li-Hong
    Zhang, Xiao-Zhen
    Lao, Meng-Yi
    Zhang, Han-Jia
    Yang, Han-Shen
    Bai, Xue-Li
    [J]. CANCERS, 2023, 15 (08)
  • [8] SPARC: A Potential Prognostic and Therapeutic Target in Pancreatic Cancer
    Vaz, Juan
    Ansari, Daniel
    Sasor, Agata
    Andersson, Roland
    [J]. PANCREAS, 2015, 44 (07) : 1024 - 1035
  • [9] Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccines
    Oladejo, Mariam
    Paulishak, Wyatt
    Wood, Laurence
    [J]. SEMINARS IN CANCER BIOLOGY, 2023, 88 : 81 - 95
  • [10] Investigation of the effects of the toll-like receptor 4 pathway on immune checkpoint vista in pancreatic cancer
    Topcu, Kubra Sena Bas
    Korucu, Emine Nedime
    Menevse, Esma
    Kocak, Nadir
    Duran, Tugce
    [J]. INVESTIGATIONAL NEW DRUGS, 2022, 40 (03) : 519 - 528
12345